Weng Lifeng, Yu Mengxia
Department of Ultrasound Medicine, Changzhou Second People's Hospital, Changzhou, Jiangsu 213004, China.
Curr Med Imaging. 2023 Oct 31. doi: 10.2174/0115734056257195231025072821.
Breast cancer, one of the most prevalent malignant tumors in females, usually occurs in the breast epithelial tissues.
The study aimed to explore the diagnostic value of contrast-enhanced ultrasound (CEUS) combined with shear wave elastography (SWE) in the diagnosis of benign and malignant breast masses in BI-RADS (Breast Imaging Reporting and Data System) 4.
Examination outcomes and clinical information of 83 patients with BI-RADS 4 breast masses were analyzed retrospectively. These included patients who received CEUS, SWE, and pathological examinations. The difference of CEUS in determining the classification of BI-RADS 4 breast masses was evaluated using histopathological outcomes of breast masses as a reference standard. The diagnostic value of CEUS, SWE, and CEUS combined with SWE in the diagnosis of benign and malignant breast masses in BI-RADS 4 was also explored.
Pathological biopsy results revealed 63 malignant masses and 20 benign masses among 83 BI-RADS 4 breast masses, with a 75.9% incidence of malignant masses. After the diagnosis of BI-RADS 4 breast masses with CEUS, SWE, and CEUS+SWE, the incidence of malignancy was 56.6%, 78.3%, and 73.5%, respectively. CEUS+SWE showed higher sensitivity (93.7% vs. 81% and 68.3%), specificity (90% vs. 30% and 80%), positive predictive value (96.7% vs. 78.5% and 91.5%), negative predictive value (81.8% vs. 33.3% and 44.4%), and diagnostic coincidence rate (92.8% vs. 68.7% and 71.1%) than SWE and CEUS alone in diagnosing pathological type of breast masses. Moreover, CEUS combined with SWE exhibited a larger area under the receiver operating characteristic (ROC) curve (0.918) than SWE (0.741, p = 0.028) and CEUS (0.555, p < 0.001) alone in the diagnosis of BI-RADS 4 breast masses.
Overall, the diagnostic value of CEUS+SWE for the pathological type of BI-RADS is preferred over CEUS and SWE alone. CEUS+SWE showed higher values than CEUS and SWE alone in diagnosing BI-RADS 4 breast masses. Specifically, CEUS+SWE can correctly identify benign and malignant masses, reduce unnecessary trauma, and avoid misdiagnosis. In summary, CEUS combined with SWE can serve as an effective diagnostic method and avoid delaying the best treatment opportunity for some malignant lesions.
乳腺癌是女性中最常见的恶性肿瘤之一,通常发生于乳腺上皮组织。
本研究旨在探讨超声造影(CEUS)联合剪切波弹性成像(SWE)在乳腺影像报告和数据系统(BI-RADS)4类乳腺肿块良恶性诊断中的价值。
回顾性分析83例BI-RADS 4类乳腺肿块患者的检查结果及临床资料,这些患者均接受了CEUS、SWE及病理检查。以乳腺肿块的组织病理学结果为参照标准,评估CEUS在判断BI-RADS 4类乳腺肿块分类方面的差异。同时探讨CEUS、SWE及CEUS联合SWE在BI-RADS 4类乳腺肿块良恶性诊断中的价值。
病理活检结果显示,83例BI-RADS 4类乳腺肿块中,恶性肿块63例,良性肿块20例,恶性肿块发生率为75.9%。采用CEUS、SWE及CEUS+SWE诊断BI-RADS 4类乳腺肿块后,恶性肿块发生率分别为56.6%、78.3%和73.5%。在诊断乳腺肿块病理类型方面,CEUS+SWE较单独使用SWE和CEUS具有更高的敏感性(93.7% vs. 81%和68.3%)、特异性(90% vs. 30%和80%)、阳性预测值(96.7% vs. 78.5%和91.5%)、阴性预测值(81.8% vs. 33.3%和44.4%)及诊断符合率(92.8% vs. 68.7%和71.1%)。此外,在诊断BI-RADS 4类乳腺肿块时,CEUS联合SWE的受试者操作特征曲线(ROC)下面积(0.918)大于单独使用SWE(0.741,p = 0.028)和CEUS(0.555,p < 0.001)。
总体而言,CEUS+SWE对BI-RADS病理类型的诊断价值优于单独使用CEUS和SWE。在诊断BI-RADS 4类乳腺肿块方面,CEUS+SWE较单独使用CEUS和SWE具有更高的价值。具体而言,CEUS+SWE能够正确鉴别良恶性肿块,减少不必要的创伤,避免误诊。总之,CEUS联合SWE可作为一种有效的诊断方法,避免延误某些恶性病变的最佳治疗时机。